Edwards Lifesciences | EW - Aktuelle Verpflichtungen

Aktienkurs
84.15
Täglich Wechseln
4.43 5.56%
Monatlich
1.79%
Jährlich
10.67%
Q2 Prognose
82.35




Aktuelle Verpflichtungen Veränderung Datum
Abbott USD 16.5B 1.91B 2025-12
Artivion USD 101.56M 15.72M 2025-12
AtriCure USD 81.52M 3.68M 2025-12
Baxter International USD 2.97B 805M 2025-12
Becton, Dickinson and Co. USD 8.76B 448M 2025-12
Boston Scientific USD 5.44B 111M 2025-12
Cooper Companies USD 1.6B 482.9M 2025-12
Dexcom USD 2.14B 1.19B 2025-12
Edwards Lifesciences USD 1.81B 225.7M 2025-12
Globus Medical USD 498.5M 32.54M 2025-12
ICU Medical USD 498.86M 5.96M 2025-12
Inogen USD 64.94M 2.12M 2025-09
Insulet USD 680.1M 32.4M 2025-12
Integra LifeSciences USD 455.98M 91.93M 2025-12
Intuitive Surgical USD 2.51B 3.2M 2026-03
J&J USD 57.72B 3.59B 2026-03
Masimo USD 371.6M 1.9M 2025-12
Medtronic USD 9.5B 440M 2025-12
Merit Medical Systems USD 239.76M 9.29M 2025-12
Stryker USD 7.79B 380M 2025-12
Tandem Diabetes Care USD 242.72M 9.82M 2025-12
Teleflex USD 762.03M 11.01M 2025-12
Zimmer Biomet Holdings USD 2.58B 180.8M 2025-12